BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21833012)

  • 1. Erythropoietin restores C-fiber function and prevents pressure ulcer formation in diabetic mice.
    Demiot C; Sarrazy V; Javellaud J; Gourloi L; Botelle L; Oudart N; Achard JM
    J Invest Dermatol; 2011 Nov; 131(11):2316-22. PubMed ID: 21833012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candesartan restores pressure-induced vasodilation and prevents skin pressure ulcer formation in diabetic mice.
    Danigo A; Nasser M; Bessaguet F; Javellaud J; Oudart N; Achard JM; Demiot C
    Cardiovasc Diabetol; 2015 Feb; 14():26. PubMed ID: 25888905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effect of erythropoietin against pressure ulcer in a mouse model of small fiber neuropathy.
    Danigo A; Magy L; Richard L; Desmoulière A; Bourthoumieu S; Funalot B; Demiot C
    PLoS One; 2014; 9(11):e113454. PubMed ID: 25422898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preservation of pressure-induced cutaneous vasodilation by limiting oxidative stress in short-term diabetic mice.
    Demiot C; Fromy B; Saumet JL; Sigaudo-Roussel D
    Cardiovasc Res; 2006 Jan; 69(1):245-52. PubMed ID: 16266692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldose reductase pathway inhibition improved vascular and C-fiber functions, allowing for pressure-induced vasodilation restoration during severe diabetic neuropathy.
    Demiot C; Tartas M; Fromy B; Abraham P; Saumet JL; Sigaudo-Roussel D
    Diabetes; 2006 May; 55(5):1478-83. PubMed ID: 16644708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin both protects from and reverses experimental diabetic neuropathy.
    Bianchi R; Buyukakilli B; Brines M; Savino C; Cavaletti G; Oggioni N; Lauria G; Borgna M; Lombardi R; Cimen B; Comelekoglu U; Kanik A; Tataroglu C; Cerami A; Ghezzi P
    Proc Natl Acad Sci U S A; 2004 Jan; 101(3):823-8. PubMed ID: 14718663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early endothelial dysfunction severely impairs skin blood flow response to local pressure application in streptozotocin-induced diabetic mice.
    Sigaudo-Roussel D; Demiot C; Fromy B; Koïtka A; Lefthériotis G; Abraham P; Saumet JL
    Diabetes; 2004 Jun; 53(6):1564-9. PubMed ID: 15161762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin protects retinal neurons and glial cells in early-stage streptozotocin-induced diabetic rats.
    Zhu B; Wang W; Gu Q; Xu X
    Exp Eye Res; 2008 Feb; 86(2):375-82. PubMed ID: 18191124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric ulcer healing and stress-lesion preventive properties of pioglitazone are attenuated in diabetic rats.
    Konturek PC; Brzozowski T; Burnat G; Szlachcic A; Koziel J; Kwiecien S; Konturek SJ; Harsch IA
    J Physiol Pharmacol; 2010 Aug; 61(4):429-36. PubMed ID: 20814070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic exercise on endothelial dysfunction and insulin signaling of cutaneous microvascular in streptozotocin-induced diabetic rats.
    Heidarianpour A; Hajizadeh S; Khoshbaten A; Niaki AG; Bigdili MR; Pourkhalili K
    Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):746-52. PubMed ID: 18043294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats.
    Mitsuhashi J; Morikawa S; Shimizu K; Ezaki T; Yasuda Y; Hori S
    Exp Eye Res; 2013 Jan; 106():64-73. PubMed ID: 23178551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subretinal delivery of AAV2-mediated human erythropoietin gene is protective and safe in experimental diabetic retinopathy.
    Xu H; Zhang L; Gu L; Lu L; Gao G; Li W; Xu G; Wang J; Gao F; Xu JY; Yao J; Wang F; Zhang J; Xu GT
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1519-30. PubMed ID: 24508793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction, macrophage infiltration and NADPH oxidase-dependent superoxide production were attenuated by erythropoietin in streptozotocin-induced diabetic rat aorta.
    Wang J; Toba H; Morita Y; Nakashima K; Noda K; Tian W; Kobara M; Nakata T
    Pharmacology; 2013; 91(1-2):48-58. PubMed ID: 23154660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ₂₅₋₃₅ non-transgenic mouse model of Alzheimer's disease.
    Maurice T; Mustafa MH; Desrumaux C; Keller E; Naert G; de la C García-Barceló M; Rodríguez Cruz Y; Garcia Rodríguez JC
    J Psychopharmacol; 2013 Nov; 27(11):1044-57. PubMed ID: 23813967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic skin ulcers in individuals with anemia of chronic disease using recombinant human erythropoietin (EPO): a review of four cases.
    Keast DH; Fraser C
    Ostomy Wound Manage; 2004 Oct; 50(10):64-70. PubMed ID: 15509883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO).
    Chen G; Shi JX; Hang CH; Xie W; Liu J; Liu X
    Neurosci Lett; 2007 Oct; 425(3):177-82. PubMed ID: 17825990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin decreases carbon tetrachloride-induced hepatic fibrosis by inhibiting transforming growth factor-beta.
    Park SY; Lee JY; Tak WY; Kweon YO; Lee MS
    Chin Med J (Engl); 2012 Sep; 125(17):3098-103. PubMed ID: 22932188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurogenic cutaneous vasodilatation and plasma extravasation in diabetic rats: effect of insulin and nerve growth factor.
    Bennett GS; Garrett NE; Diemel LT; Brain SD; Tomlinson DR
    Br J Pharmacol; 1998 Aug; 124(7):1573-9. PubMed ID: 9723973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early treatment of premature infants with recombinant human erythropoietin.
    Messer J; Haddad J; Donato L; Astruc D; Matis J
    Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine pathway involvement in the loss of the cutaneous pressure-induced vasodilatation during acute pain in rats.
    Fromy B; Sigaudo-Roussel D; Baron C; Roquelaure Y; Leftheriotis G; Saumet JL
    J Physiol; 2007 Feb; 579(Pt 1):247-54. PubMed ID: 17158176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.